Pembrolizumab Plus Pemetrexed and Platinum in Nonsquamous Non–Small-Cell Lung Cancer: 5-Year Outcomes From the Phase 3 KEYNOTE-189 Study

por Garassino, Marina C., Gadgeel, Shirish, Speranza, Giovanna, Felip, Enriqueta, Esteban, Emilio, Dómine, Manuel, Hochmair, Maximilian J., Powell, Steven F., Bischoff, Helge G., Peled, Nir, Grossi, Francesco, Jennens, Ross R., Reck, Martin, Hui, Rina, Garon, Edward B., Kurata, Takayasu, Gray, Jhanelle E., Schwarzenberger, Paul, Jensen, Erin, Pietanza, M. Catherine, Rodríguez-Abreu, Delvys
Publicado 2023

Phase 1, open-label, dose-escalation study on the safety, pharmacokinetics, and preliminary efficacy of intravenous Coxsackievirus A21 (V937), with or without pembrolizumab, in pat...

por Rudin, Charles M, Pandha, Hardev S, Zibelman, Matthew, Akerley, Wallace L, Harrington, Kevin J, Day, Daphne, Hill, Andrew G, O'Day, Steven J, Clay, Timothy D, Wright, Gavin M, Jennens, Ross R, Gerber, David E, Rosenberg, Jonathan E, Ralph, Christy, Campbell, David C, Curti, Brendan D, Merchan, Jaime R, Ren, Yixin, Schmidt, Emmett V, Guttman, Lisa, Gupta, Sumati
Publicado 2023